See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2017_Corvus_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001626971')"} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 136,033,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 3,248,000 |
3 | remainder_Assets | 869,000 |
4 | LiabilitiesCurrent | 5,944,000 |
5 | LiabilitiesNoncurrent | 1,405,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 7,620,000 |
9 | ResearchAndDevelopmentExpense | 29,356,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 601,000 |
13 | remainder_ComprehensiveNetIncome | 6,000 |
yvar | yval | |
---|---|---|
0 | Assets | 140,150,000 |
1 | Liabilities | 7,349,000 |
2 | Expenses | 36,976,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 132,801,000 |
5 | NetIncome | -36,375,000 |
6 | ComprehensiveNetIncome | -36,372,000 |
7 | BaseVar | 92,541,000 |
8 | EconomicCapitalRatio | 2.60 |